Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Symptom Burden of Busulfan and Melphalan Versus Melphalan Alone for Multiple Myeloma

Loretta A. Williams, PhD MSN, BSN, BA, Muzaffar H. Qazilbash, MD, Qiuling Shi, MD PhD, Qaiser Bashir, MD MBBS, Huei K. Lin, MS, Charles S. Cleeland, PhD, Richard E. Champlin, MD

Blood (2017) 130 (Supplement 1): 681.

https://doi.org/10.1182/blood.V130.Suppl_1.681.681

Published: 2017

Journal Articles

Pralatrexate in Combination with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL): A Phase 1 Dose-Escalation Study

Andrei Shustov, MD, Patrick B Johnston, MD PhD, Stefan Klaus Barta, MDMRCP,MS, Gajanan Bhat, Guru Reddy, Yasuhiro Oki, MD

Blood (2017) 130 (Supplement 1): 818.

https://doi.org/10.1182/blood.V130.Suppl_1.818.818

Published: 2017

Journal Articles

Melflufen Therapy for Relapsed Refractory Multiple Myeloma (RRMM) Patients Refractory to Daratumumab and/or Pomalidomide: A Report on Early Efficacy

Blood (2017) 130 (Supplement 1): 1841.

https://doi.org/10.1182/blood.V130.Suppl_1.1841.1841

Published: 2017

Journal Articles

Combination Treatment of Rituximab, Cyclophosphamide, and Dexamethasone for Warm Autoimmune Hemolytic Anemia

Hillel Bocian, MD, Caroline Piatek, MD, Howard A Liebman, MD, Casey L O'Connell, MD, Ilene Ceil Weitz, MD, Cage Saul Johnson, MD

Blood (2016) 128 (22): 4802.

https://doi.org/10.1182/blood.V128.22.4802.4802

Published: 2016

Journal Articles

Dentist to Oncologist: Gingival Hyperplasia in AML Accompanied By Periodontal Infection- Case Report

Abdulraheem Yacoub, MD, Gauranga Mahalwar

Blood (2016) 128 (22): 5187.

https://doi.org/10.1182/blood.V128.22.5187.5187

Published: 2016

Journal Articles

A Randomized Phase 2 Placebo Controlled Trial of Clobetasol Rinse for Treatment of Oral Chronic Graft-Versus-Host Disease

Jacqueline W. Mays, DDS, MHSc, PhD, Lauren M. Curtis, MD, Carol Bassim, DMD, MS, Seth M. Steinberg, PhD, David Venzon, PhD, Jeremy J. Rose, MS, Monica Cho, Christopher G. Kanakry, MD, Fahd Yazdanie, Daniele Avila, NP, Kristin Baird, MD, Jennifer Hsu, RN, Licia Masuch, George Grimes, RPh, Judith Starling, RPh, Daniel H. Fowler, MD, Ronald E. Gress, MD, Fran T. Hakim, PhD, Steven Z. Pavletic, MD

Blood (2016) 128 (22): 826.

https://doi.org/10.1182/blood.V128.22.826.826

Published: 2016

Journal Articles

Fertility Preservation for Women with Sickle Cell Disease (SCD)

Torie C Plowden, MDMPH, Nicole M Millan, BS, Carter M Owen, MD, Mae W Healy, DO, Nicole K Banks, MD, Matthew Hsieh, MD, Courtney D. Fitzhugh, MD, Jeannine Witmyer, PhD, Doug Peak, BS, TS (ABB), David Frankfurter, MD, Alan H DeCherney, MD, John F Tisdale, MD, Erin F Wolff, MD

Blood (2015) 126 (23): 3408.

https://doi.org/10.1182/blood.V126.23.3408.3408

Published: 2015

Journal Articles

The Efficacy of Oral Elemental Diet in Patients with Hematopoietic Stem Cell Transplantation

Takanobu Morishita, MD, Natsuko Tsushita, MD, Kanae Imai, MD, Toshiyasu Sakai, MD, Kotaro Miyao, MD, Reona Sakemura, MD, Tomonori Kato, MDPhD, Keiko Niimi, MD, Yoshitaka Ono, MD, Masashi Sawa, MD PhD

Blood (2014) 124 (21): 1136.

https://doi.org/10.1182/blood.V124.21.1136.1136

Published: 2014

Journal Articles

A First-In-Human Phase 1 Study Of The Antibody-Drug Conjugate SGN-CD19A In Relapsed Or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

Uma Borate, MD, Amir T. Fathi, MD, Bijal D. Shah, MD, Daniel J. DeAngelo, MD, Ph.D, Lewis B. Silverman, MD, Todd Michael Cooper, Tina M. Albertson, MD, PhD, Megan M. O'Meara, MD, Larissa Sandalic, MS, Faith Stevison, MS, Robert Chen, MD

Blood (2013) 122 (21): 1437.

https://doi.org/10.1182/blood.V122.21.1437.1437

Published: 2013

Journal Articles

Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease

Laura M. De Castro, MD, Ted Wun, MD, Sophie Lanzkron, MD MHS, Wally R. Smith, MD, Kathryn L. Hassell, MD, Abdullah Kutlar, MD, Kim Smith-Whitley, MD, Seungshin Rhee, MS, Marilyn J. Telen, MD, Helen Thackray, MD

Blood (2013) 122 (21): 775.

https://doi.org/10.1182/blood.V122.21.775.775

Published: 2013

Journal Articles

GMI 1070: Reduction In Time To Resolution Of Vaso-Occlusive Crisis and Decreased Opioid Use In a Prospective, Randomized, Multi-Center Double Blind, Adaptive Phase 2 Study In Sickle Cell Disease

Marilyn J. Telen, MD, Ted Wun, MD, Timothy L. McCavit, MD, MS, Laura M. De Castro, MD, Lakshmanan Krishnamurti, MD, Sophie Lanzkron, MD, MHS, Lewis L. Hsu, MD, PhD, Wally R. Smith, MD, Seungshin Rhee, MS, John L. Magnani, PhD, Helen Thackray, MD

Blood (2013) 122 (21): 776.

https://doi.org/10.1182/blood.V122.21.776.776

Published: 2013

Journal Articles

Calculated NIH Response Correlates with Changes in Patient-Reported Symptoms but Not with Quality of Life: Results From the Chronic Gvhd Consortium

Yoshihiro Inamoto, MD, Corey S. Cutler, MD, MPH, FRCPC, Xiaoyu Chai, MS, Mukta Arora, MD, Paul J. Martin, MD, Joseph Pidala, MD, MS, Jeanne Palmer, MD, Steven Z. Pavletic, MD, Madan H. Jagasia, MD, David Jacobsohn, MD, Paul A. Carpenter, MD, Mary E.D. Flowers, MD, Nandita Khera, MD, Georgia B. Vogelsang, MD, Daniel J. Weisdorf, MD, Barry Storer, PhD, Stephanie J. Lee, MD, MPH

Blood (2011) 118 (21): 1988.

https://doi.org/10.1182/blood.V118.21.1988.1988

Published: 2011

Journal Articles

Low Incidence of Severe Mucositis After Myeloablative, HLA-Matched Bone Marrow Transplantation and High Dose, Post-Transplantation Cyclophosphamide

Wendy Ying, BA, Tracy T. Douglas, RN, MSN, Nadira Durakovic, MD, PhD, Sallie Brovitz-Palmer, RN, MSN, AOCNS, Lindsey Lombardi Thomas, PharmD, Richard J. Jones, Leo Luznik, Ephraim J. Fuchs

Blood (2011) 118 (21): 893.

https://doi.org/10.1182/blood.V118.21.893.893

Published: 2011

Journal Articles

Assessing the Validity of the NIH Response Criteria for Chronic Graft-Versus-Host Disease (cGVHD): Consensus Measures Correlate with Clinical Outcomes,

Blood (2011) 118 (21): 4074.

https://doi.org/10.1182/blood.V118.21.4074.4074

Published: 2011

Journal Articles

Differences Between Hematologist and Hospitalist Caring for Patients with Sickle Cell Disease Hospitalized for Vaso-Occlusive Crisis,

Nirmish Shah, MD, Margo Renee Rollins, Daniel Landi, Regina Crawford, MD, Laura M DeCastro, MD

Blood (2011) 118 (21): 4185.

https://doi.org/10.1182/blood.V118.21.4185.4185

Published: 2011

Journal Articles

Unexpected 5 Year Survival Benefit in Patients Given Oral Cryotherapy During Conditioning for Stem Cell Transplantation. A Prospective Randomized Study

Anncarin Svanberg, Kerstin Öhrn, Gunnar Birgegard, MD, PhD

Blood (2011) 118 (21): 4559.

https://doi.org/10.1182/blood.V118.21.4559.4559

Published: 2011

Journal Articles

Interim Analysis of Randomized Phase II Study of Recombinant Human Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy with Stem Cell Transplantation for Hematologic Malignancies

Ji-Won Kim, Kyung Im Kim, Hyun Jung Lee, Byung-Su Kim, Soo-Mee Bang, Inho Kim, Jung Mi Oh, Sung-Soo Yoon, Jong Seok Lee, Seonyang Park, Byoung Kook Kim

Blood (2010) 116 (21): 905.

https://doi.org/10.1182/blood.V116.21.905.905

Published: 2010

Journal Articles

Validation of the NIH Criteria of the Severity Grading of Chronic Gvhd – Results of a Prospective German Multicenter Validation Trial.

Daniel Wolff, Philipp Herzberg, Pia Heussner, Friederike Mumm, Inken Hilgendorf, MD, Stephanie von Harsdorf, MD, Philipp Hemmati, Armin Gerbitz, MD, Michael Schmitt, Ernst Holler, PhD, Hildegard Greinix

Blood (2009) 114 (22): 204.

https://doi.org/10.1182/blood.V114.22.204.204

Published: 2009

Journal Articles

Rituximab Therapy for Steroid-Refractory Chronic GVHD: Safety and Efficacy Analysis.

Corey Cutler, MD MPH FRCPC, David Miklos, MD PhD, Stephanie J. Lee, MD MPH, Sook-Bin Woo, DMD, Nathaniel Treister, DMD, Don Bienfang, MD, Lloyd Klickstein, MD PhD, Jesse Levin, BA, Katherine H. Miller, BA, Carol Reynolds, PhD, Mildred Pasek, RN, Vincent Ho, MD, Jerome Ritz, MD PhD, Joseph H. Antin, MD, Robert Soiffer, MD, Edwin Alyea, MD

Blood (2004) 104 (11): 2251.

https://doi.org/10.1182/blood.V104.11.2251.2251

Published: 2004

NARROW

Symptom Burden of Busulfan and Melphalan Versus Melphalan Alone for Multiple Myeloma

Pralatrexate in Combination with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL): A Phase 1 Dose-Escalation Study

Melflufen Therapy for Relapsed Refractory Multiple Myeloma (RRMM) Patients Refractory to Daratumumab and/or Pomalidomide: A Report on Early Efficacy

Combination Treatment of Rituximab, Cyclophosphamide, and Dexamethasone for Warm Autoimmune Hemolytic Anemia

Dentist to Oncologist: Gingival Hyperplasia in AML Accompanied By Periodontal Infection- Case Report

A Randomized Phase 2 Placebo Controlled Trial of Clobetasol Rinse for Treatment of Oral Chronic Graft-Versus-Host Disease

Fertility Preservation for Women with Sickle Cell Disease (SCD)

The Efficacy of Oral Elemental Diet in Patients with Hematopoietic Stem Cell Transplantation

A First-In-Human Phase 1 Study Of The Antibody-Drug Conjugate SGN-CD19A In Relapsed Or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease

GMI 1070: Reduction In Time To Resolution Of Vaso-Occlusive Crisis and Decreased Opioid Use In a Prospective, Randomized, Multi-Center Double Blind, Adaptive Phase 2 Study In Sickle Cell Disease

Calculated NIH Response Correlates with Changes in Patient-Reported Symptoms but Not with Quality of Life: Results From the Chronic Gvhd Consortium

Low Incidence of Severe Mucositis After Myeloablative, HLA-Matched Bone Marrow Transplantation and High Dose, Post-Transplantation Cyclophosphamide

Assessing the Validity of the NIH Response Criteria for Chronic Graft-Versus-Host Disease (cGVHD): Consensus Measures Correlate with Clinical Outcomes,

Differences Between Hematologist and Hospitalist Caring for Patients with Sickle Cell Disease Hospitalized for Vaso-Occlusive Crisis,

Unexpected 5 Year Survival Benefit in Patients Given Oral Cryotherapy During Conditioning for Stem Cell Transplantation. A Prospective Randomized Study

Interim Analysis of Randomized Phase II Study of Recombinant Human Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy with Stem Cell Transplantation for Hematologic Malignancies

Validation of the NIH Criteria of the Severity Grading of Chronic Gvhd – Results of a Prospective German Multicenter Validation Trial.

Rituximab Therapy for Steroid-Refractory Chronic GVHD: Safety and Efficacy Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only